Table 5.
MetS Related Predictors of Malignant Neoplasms in Patients with T2DM (Multivariate Logistic Regression Model; Nagelkerke R2=0.586)
| Variable | OR | 95% CI | |
|---|---|---|---|
| Lower | Upper | ||
| T2DM duration (years)* | 1.112 | 1.083 | 1.258 |
| BMI (kg/m2) | 1.014 | 1.001 | 1.075 |
| AC (cm) | 1.029 | 1.017 | 1.102 |
| Triglycerides (mg/dL) | 1.008 | 0.981 | 1.012 |
| HDLc (mg/dL)* | 0.902 | 0.843 | 0.964 |
| LDLc (mg/dL)* | 1.108 | 1.031 | 1.210 |
| Hypertension* | 10.187 | 2.123 | 18.873 |
| Insulin-based treatment* | 10.585 | 1.995 | 16.152 |
Note: *Predictor variable is significant both independently and as a co-factor.
Abbreviations: T2DM, type 2 diabetes mellitus; BMI, body mass index; AC, abdominal circumference; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol.